Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparative analysis of anticholinergic burden scales to explain iatrogenic cognitive impairment in schizophrenia: results from the multicenter FACE-SZ cohort.
Vidal N, Roux P, Urbach M, Belmonte C, Boyer L, Capdevielle D, Clauss-Kobayashi J, D'Amato T, Dassing R, Dubertret C, Dubreucq J, Fond G, Honciuc RM, Leignier S, Llorca PM, Mallet J, Misdrahi D, Pignon B, Rey R, Schürhoff F, Tessier A; FACE-SZ (FondaMental Academic Centers of Expertise—Schizophrenia) Group; Passerieux C, Brunet-Gouet E. Vidal N, et al. Among authors: d amato t. Front Pharmacol. 2024 Jun 12;15:1403093. doi: 10.3389/fphar.2024.1403093. eCollection 2024. Front Pharmacol. 2024. PMID: 38933674 Free PMC article.
Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort.
Godin O, Leboyer M, Gaman A, Aouizerate B, Berna F, Brunel L, Capdevielle D, Chereau I, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Le Strat Y, Llorca PM, Misdrahi D, Rey R, Richieri R, Passerieux C, Schandrin A, Schürhoff F, Urbach M, Vidalhet P, Girerd N, Fond G; FACE-SZ group. Godin O, et al. Schizophr Res. 2015 Oct;168(1-2):388-94. doi: 10.1016/j.schres.2015.07.047. Schizophr Res. 2015. PMID: 26255568
Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset.
Berna F, Misdrahi D, Boyer L, Aouizerate B, Brunel L, Capdevielle D, Chereau I, Danion JM, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Lancon C, Mallet J, Rey R, Passerieux C, Schandrin A, Schurhoff F, Tronche AM, Urbach M, Vidailhet P, Llorca PM, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Berna F, et al. Schizophr Res. 2015 Dec;169(1-3):255-261. doi: 10.1016/j.schres.2015.10.040. Epub 2015 Nov 15. Schizophr Res. 2015. PMID: 26589388
Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort.
Fond G, Berna F, Andrianarisoa M, Godin O, Leboyer M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Gabayet F, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Richieri R, Rey R, Schandrin A, Urbach M, Vidailhet P, Boyer L, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Fond G, et al. Eur Arch Psychiatry Clin Neurosci. 2017 Aug;267(5):465-472. doi: 10.1007/s00406-017-0771-4. Epub 2017 Feb 25. Eur Arch Psychiatry Clin Neurosci. 2017. PMID: 28238173
Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohort.
Mallet J, Le Strat Y, Schürhoff F, Mazer N, Portalier C, Andrianarisoa M, Aouizerate B, Berna F, Brunel L, Capdevielle D, Chereau I, D'Amato T, Denizot H, Dubreucq J, Faget C, Gabayet F, Lançon C, Llorca PM, Misdrahi D, Rey R, Roux P, Schandrin A, Urbach M, Vidailhet P, Fond G, Dubertret C; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Mallet J, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):332-339. doi: 10.1016/j.pnpbp.2017.06.026. Epub 2017 Jun 27. Prog Neuropsychopharmacol Biol Psychiatry. 2017. PMID: 28663115
Predictors of rapid high weight gain in schizophrenia: Longitudinal analysis of the French FACE-SZ cohort.
Godin O, Leboyer M, Schürhoff F, Boyer L, Andrianarisoa M, Brunel L, Bulzacka E, Aouizerate B, Berna F, Capdevielle D, D'Amato T, Denizot H, Dubertret C, Dubreucq J, Faget C, Gabayet F, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Richieri R, Schandrin A, Urbach M, Vidailhet P, Costagliola D, Fond G; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Godin O, et al. J Psychiatr Res. 2017 Nov;94:62-69. doi: 10.1016/j.jpsychires.2017.06.008. Epub 2017 Jun 20. J Psychiatr Res. 2017. PMID: 28668717
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ dataset.
Fond G, Boyer L, Andrianarisoa M, Godin O, Brunel L, Bulzacka E, Coulon N, Llorca PM, Berna F, Aouizerate B, Capdevielle D, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Misdrahi D, Rey R, Richieri R, Roux P, Passerieux C, Schandrin A, Tronche AM, Vidailhet P, Leboyer M, Schürhoff F; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Fond G, et al. Schizophr Res. 2018 May;195:529-533. doi: 10.1016/j.schres.2017.08.058. Epub 2017 Sep 6. Schizophr Res. 2018. PMID: 28888362
Influence of Venus and Mars in the cognitive sky of schizophrenia. Results from the first-step national FACE-SZ cohort.
Fond G, Boyer L, Leboyer M, Godin O, Llorca PM, Andrianarisoa M, Berna F, Brunel L, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Misdrahi D, Rey R, Lancon C, Passerieux C, Roux P, Vidailhet P, Yazbek H, Schürhoff F, Bulzacka E; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Fond G, et al. Schizophr Res. 2018 May;195:357-365. doi: 10.1016/j.schres.2017.09.027. Epub 2017 Sep 30. Schizophr Res. 2018. PMID: 28974404
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort.
Fond G, Resseguier N, Schürhoff F, Godin O, Andrianarisoa M, Brunel L, Bulzacka E, Aouizerate B, Berna F, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Lançon C, Llorca PM, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Boyer L, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Fond G, et al. Eur Arch Psychiatry Clin Neurosci. 2018 Sep;268(6):541-553. doi: 10.1007/s00406-017-0847-1. Epub 2017 Nov 10. Eur Arch Psychiatry Clin Neurosci. 2018. PMID: 29127503
Tobacco smoking is associated with antipsychotic medication, physical aggressiveness, and alcohol use disorder in schizophrenia: results from the FACE-SZ national cohort.
Mallet J, Le Strat Y, Schürhoff F, Mazer N, Portalier C, Andrianarisoa M, Aouizerate B, Berna F, Brunel L, Capdevielle D, Chereau I, D'Amato T, Dubreucq J, Faget C, Gabayet F, Honciuc RM, Lançon C, Llorca PM, Misdrahi D, Rey R, Roux P, Schandrin A, Urbach M, Vidailhet P, Fond G, Dubertret C; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group. Mallet J, et al. Eur Arch Psychiatry Clin Neurosci. 2019 Jun;269(4):449-457. doi: 10.1007/s00406-018-0873-7. Epub 2018 Feb 2. Eur Arch Psychiatry Clin Neurosci. 2019. PMID: 29396753
223 results